First pre-surgery breast cancer drug approved by FDA

[News]

The US Food and Drug Administration (FDA) has approved the first drug to be used in early stage breast cancer treatment. Perjeta (pertuzumab) will be used as part of a complete treatment regimen for patients before surgery (neoadjuvant setting)...

More... (http://www.medicalnewstoday.com/articles/266828.php)